Fingerprint
Dive into the research topics of 'Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically